Philips secures FDA clearance for Verida spectral CT system

Last month, Philips obtained FDA clearance for DeviceGuide, an AI-based software designed to provide physicians with ...
Pharmabiz

Royal Philips receives US FDA 510(k) clearance for Verida, an AI-powered detector-based spectral CT to advance diagnostic precision

Royal Philips receives US FDA 510(k) clearance for Verida, an AI-powered detector-based spectral CT to advance diagnostic precision: Amsterdam, the Netherlands Saturday, April 18, ...

Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications

April 16, 2026Combining always-on spectral imaging with AI reconstruction to deliver enhanced levels of image quality, efficiency, and clinical ...
MassDevice

Philips wins FDA nod for AI-powered, detector-based spectral CT tech

Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for its AI-powered Spectral CT Verida system.

Spectral AI (MDAI) Q4 2025 Earnings Transcript

Full-year 2025 financials -- Research and development revenue totaled $19.7 million (down from $29.6 million), gross margin ...

Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026

Overview Full Year Research & Development Revenue of $19.7 Million; Q4 2025 Revenue of $3.8 MillionCash Rose to $15.4 Million at December 31, ...

Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System

Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care ...